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Summary
Carcinoembryonic antigen cell adhesion molecule like I (CEACAM1) is expressed on activated T
cells and signals through either a long (L) cytoplasmic tail containing immune receptor tyrosine
based inhibitory motifs, which provide inhibitory function, or a short (S) cytoplasmic tail with an
unknown role. Previous studies on peripheral T cells show that CEACAM1-L isoforms
predominate with little to no detectable CEACAM1-S isoforms in mouse and human. We show
here that this was not the case in tissue resident T cells of intestines and gut associated lymphoid
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tissues which demonstrated predominant expression of CEACAM1-S isoforms relative to
CEACAM1-L isoforms in human and mouse. This tissue resident predominance of CEACAM1-S
expression was determined by the intestinal environment where it served a stimulatory function
leading to the regulation of T cell subsets associated with generation of secretory IgA immunity,
the regulation of mucosal commensalism, and defense of the barrier against enteropathogens.
Introduction
Carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1), a member of the
carcinoembryonic antigen family, is engaged in intercellular binding interactions that affect
signal transduction by a number of cell surface receptors. CEACAM1 is constitutively
expressed by a variety of cell types including those of endothelial, epithelial and
hematopoietic origin such as B cells, polymorphonuclear leukocytes, monocytes, and
dendritic cells. In addition, CEACAM1 is expressed at minimal quantities in circulating
natural killer (NK) and T cells but is upregulated in these cell types following a variety of
different forms of activation (Azuz-Lieberman et al., 2005; Boulton et al., 2002; Coutelier et
al., 1994; Nakajima et al., 2002; Singer et al., 2002). On the cell surface, CEACAM1 can
associate with and modify the function of numerous signaling receptors that are dictated by
the CEACAM1 isoforms expressed. The individual CEACAM1 isoforms are generated by
alternative splicing and consist of transmembrane proteins that possess a characteristic
membrane distal, IgV-like domain (the N-domain) which functions in homophilic binding
but differs with respect to the number of membrane proximal extracellular IgC2-like
domains and the length of their cytoplasmic tail (Gray-Owen et al., 2006). Specifically, the
11 human and 4 mouse CEACAM1 splice variants encode either a short (S) cytoplasmic tail
about which little is known or a long (L) cytoplasmic tail containing immune receptor
tyrosine-based inhibitory motifs (ITIM). In the latter case, consistent with the presence of
ITIM motifs in their cytoplasmic tail, the CEACAM1-L isoforms of mice and humans are
linked to inhibition of many different signaling receptors (Chen et al., 2001; Chen et al.,
2008; Kammerer et al., 1998; Pan et al., 2010). In each example, the inhibitory function of
CEACAM1-L isoforms is triggered by the phosphorylation of the ITIM tyrosine residues by
receptor tyrosine kinases or Src-related kinases, resulting in recruitment of the Src homology
2 (SH2) domain-containing protein-tyrosine phosphatases (SHP)-1 or -2 (Huber et al., 1999;
Nagaishi et al., 2006). Thus, CEACAM1-L-mediated recruitment of these phosphatases
results in the dephosphorylation of critical tyrosines contained within activating motifs
associated with a variety of cell surface receptors such as the B cell receptor, epidermal
growth factor receptor and T cell receptor (TCR)-CD3 complex (Abou-Rjaily et al., 2004;
Boulton et al., 2002; Chen et al., 2008; Lobo et al., 2009). As such, CEACAM1-L isoforms
are functionally inhibitory and are the major isoforms described in mouse and human
lymphocytes including NK cells, B cells and T cells.
CEACAM1-L and CEACAM1-S isoforms are expressed at varying ratios in different cell
types with recent evidence showing that such expression is under the influence of cytokines
(e.g. interferon-γ), transcription factors (e.g. IRF-1) and splicing regulators (e.g. members of
the heterogeneous nuclear ribonucleoprotein family) (Dery et al. 2011; Gencheva et al.,
2010). Although not directly demonstrated, this is presumed to be the case for T
lymphocytes as well. It is known that while mouse and human T cells predominantly express
CEACAM1-L isoforms, there is some evidence that CEACAM1-S isoforms can be
expressed. However, this is a controversial issue as little or no detection has been described
depending upon the study (Donda et al., 2000; Singer et al., 2002). This is not an
inconsequential issue as in vitro transfection studies in T cells suggest that CEACAM1 is a
‘tunable’ receptor system given that CEACAM1-S isoforms may possess co-stimulatory
function that is capable of ameliorating the inhibitory signals provided by CEACAM1-L
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isoforms in the context of TCR-CD3 complex signaling when expressed together (Chen et
al., 2004a; Chen et al., 2008). However, there is no information available on CEACAM1
isoform regulation in T cells in vivo and the physiologic function(s) that this might confer.
To this end, we have focused our attention on the regulation of CEACAM1 isoform
expression and function within intestinal tissues in order to shed light on the normal
physiologic roles of CEACAM1 in these compartments. We have done so given the fact that
CEACAM1 can function as a microbial receptor and the gastrointestinal surface is in direct
contact with large concentrations of commensal and pathogenic microbes (Kuespert et al.,
2006). In addition, CEACAM1 expression is increased on the cell surface of T cells in
human diseases such as Celiac disease and inflammatory bowel disease (Donda et al., 2000;
Morales et al., 1999). Furthermore, in vivo ligation of CEACAM1 with CEACAM1
homophilic ligands as provided by N-domain-Fc-fusion proteins or forced expression of
CEACAM1-L isoforms in T cells is able to prevent or block mucosal inflammation
associated with either hapten-mediated colitis or naïve T cell transfer models of colitis
(Iijima et al., 2004; Nagaishi et al., 2006). Together these studies predict an important
physiological role for CEACAM1 in mucosal tissues of the gastrointestinal tract.
In this study, we have identified a key role for CEACAM1 in regulating steady-state
secretory immunity in the intestines. By establishing a PCR method for quantifying mouse
CEACAM1-S and CEACAM1-L variants, we found that T cells within the intestines,
relative to peripheral tissues such as the spleen, not only exhibited increased overall
CEACAM1 expression but also uniquely possessed a relative overabundance of
CEACAM1-S relative to CEACAM1-L isoforms. Moreover, in this environment, we show
that CEACAM1-S isoforms have special physiological functions which at a cellular level
enhanced T cell activation independently of CEACAM1-L isoforms and were preferentially
expressed in cells performing common mucosal immune functions. Specifically, we have
found that CEACAM1-S acts as an individual signaling unit which promoted the induction
of CD4+LAP+ regulatory T (Treg) cells, CD4+PD1+CXCR5+ follicular helper T cells (Tfh
cells), and the development of IgA committed B cells within Peyer’s patches (PP).
Consistent with this, T cell-associated CEACAM1-S isoforms led to enhanced mucosal IgA
secretion which influenced both the composition of commensal microbiota and host defense
against exposure to pathogens such as Listeria monocytogenes. In the absence of
CEACAM1 expression, these barrier-protective functions were diminished. Together, these
studies provide tissue-specific evidence for CEACAM1 isoform regulation linked to
important physiological functions within the intestines.
Results
Intestinal T cells predominantly express CEACAM1-S isoforms while extraintestinal T cells
mainly express CEACAM1-L
The expression of CEACAM1 isoforms in hematopoietic cells has not been systematically
examined outside peripheral sites such as the spleen and blood. We therefore compared
CEACAM1 expression on mouse splenic T cells to the quantities expressed on T cells from
intestinal tissues under homeostatic conditions. Interestingly, the proportion of T cells that
stained positive for CEACAM1 was increased on T cells obtained from colonic lamina
propria (LP) and PP in comparison to that observed on T cells isolated from either spleen or
mesenteric lymph nodes (MLN) as defined by staining with the CC1 monoclonal antibody
(mAb), a mouse anti-mouse CEACAM1 antibody (Dveksler et al., 1993) (Figure 1A). These
studies showed that T cells within intestinal mucosal tissues displayed substantially greater
CEACAM1 amounts on the cell surface under steady-state conditions in comparison to
those within non-mucosal sites.
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We next assessed the relative expression of CEACAM1 isoforms and to do so we first
established a quantitative assay for analyzing expression of mouse CEACAM1-L and -S
variants as currently available antibodies are not able to distinguish between these two
general classes of CEACAM1 in a quantitative fashion. Two pairs of real-time PCR primers
were designed to specifically quantify these in mouse T cells. The specificity and efficiency
of these primers was verified using mouse (m) CEACAM1-4L (4L) and CEACAM1-4S (4S)
plasmids (Figure S1A). Quantitative (q)PCR analysis of mouse primary CD3+ T cells
isolated from spleen and lymph nodes (LN) demonstrated that CEACAM1-L isoforms
predominated in resting peripheral T cells with increased expression upon anti-CD3
stimulation as previously described (Boulton et al., 2002; Nakajima et al., 2002) (Figure
S1B). In addition, although CEACAM1-S isoforms were detected, CEACAM1-L isoforms
predominated in peripheral T cells such that the CEACAM1-L:CEACAM1-S (L:S) ratio
was 1.95 ± 0.34, consistent with previous studies (Singer et al., 2002).
Having validated this qPCR assay with splenic T cells, we performed a broad survey of
CEACAM1 isoform expression in primary T cells isolated from several different tissues. It
was noted that, unlike CD3+ T cells isolated from spleen or MLN wherein CEACAM1
expression was low and CEACAM1-L isoforms predominated over CEACAM1-S isoforms,
CD3+ T cells from the intestinal LP of the duodenum, jejunum, ileum or colon and PP were
observed to express an overall increase in CEACAM1 transcript abundance with
significantly greater quantities of CEACAM1-S isoforms relative to CEACAM1-L isoforms.
Thus, an average L:S ratio of <1.0 (PP: 0.53 ± 0.08; small intestine: 0.36 ± 0.11; and colon;
0.19 ± 0.04) was observed, which was reversed from peripheral T cells (Figure 1B).
Accordingly, it was noted that the quantity and L:S ratio of CEACAM1 expression varied
cephalocaudally along the axis of the gut. Specifically, the amounts of CEACAM1 and L:S
ratio were more similar to spleen, MLN and peripheral blood in the proximal intestines.
Furthermore, CEACAM1 expression increased and the L:S ratio progressively decreased
from the distal small intestine (ileum) to the colon. As a result, LP T cells of the PP and
colon contained the highest amount of CEACAM1 and the lowest L:S ratios relative to all
other compartments examined (Figure 1B). This was verified by immunoblotting with the
CC1 mAb, further confirming that T cells isolated from PP and colonic LP expressed higher
CEACAM1 amounts relative to peripheral blood and especially CEACAM1-S isoforms
which was most notable in the colonic LP (Figure S1C). These studies both confirmed the
increased expression of CEACAM1 within intestinal T cells and further indicated that
CEACAM1-S isoforms were not only expressed by primary T cells but established that they
were, surprisingly, the major isoform within intestinal T cells.
Given these observations, we also determined whether CEACAM1-S isoforms
predominated in T cells obtained from the LP of human colon. In a first group of studies, we
confirmed that, in comparison to peripheral T cells, a greater proportion of T cells from the
human colon expressed CEACAM1 on the cell surface as we had previously observed in
mouse (Figure 1C and Figure S1D). Moreover, using previously published RT-PCR primers
which amplify a 160 bp fragment from all CEACAM1-S cDNAs and a 210 bp fragment
from all CEACAM1-L cDNAs from human CEACAM1 (Chen et al., 2008; Singer et al.,
2002), we confirmed that CEACAM1 was barely detectable in resting peripheral blood T
cells (Figure 1D). However, after activation with either phytohemagglutinin (PHA) or
interleukin-2 (IL-2), CEACAM1 was induced and CEACAM1-L isoforms became the
dominant type detected (Figure 1D, left). In contrast to these observations with peripheral
blood T cells and similar to the findings obtained with intestinal T cells from mice, CD3+ T
cells from the LP of human colon exhibited readily detectable CEACAM1 at baseline with
markedly elevated quantities of CEACAM1-S relative to CEACAM1-L when compared to
that observed in CD3+ T cells from peripheral blood (Figure 1D, right).
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Preferential expression of CEACAM1-S over CEACAM1-L isoforms requires continuous
exposure to mucosa-associated factors
Together, these studies demonstrated that intestinal T cells from both mouse and human
uniquely expressed CEACAM1-S isoforms in particularly high quantities. In addition, this
dominance of CEACAM1-S expression by intestinal T cells was not simply due to T cell
activation since activation of peripheral blood T cells did not induce significant quantities of
CEACAM1-S (Figure S1B) nor were significant quantities of CEACAM1-S detectable in T
cells from the spleen or peripheral blood (Figure 1B and 1D). Given this, we hypothesized
that CEACAM1 expression and especially that of CEACAM1-S isoforms in T cells was
regulated by signals encountered within the intestinal microenvironment. We therefore
addressed this question by adoptively transferring spleen-derived, naïve CD4+CD62L+ T
cells from wild-type (WT) mice that expressed little detectable CEACAM1 expression by
flow cytometry (data not shown) but with low amounts of predominantly CEACAM1-L
transcripts as shown by qPCR into Rag2−/− mice and analyzed CEACAM1 isoform
expression in the adoptively transferred T cells after 2 weeks, prior to the development of
intestinal inflammation (Figure 1E). These studies showed that, whereas T cells isolated
from the MLN and spleens of the Rag2−/− recipients expressed low-to-moderate amounts of
CEACAM1 expression with an L:S ratio of approximately 1.0, the T cells which homed to
the LP of the colon expressed substantially increased CEACAM1 with an L:S ratio of
approximately 0.1–0.2 consistent with a significant dominance of CEACAM1-S isoforms.
Thus, peripheral T cells entering the intestines expressed not only increased quantities of
CEACAM1 but also a marked dominance of CEACAM1-S isoforms.
We also questioned whether these effects by intestinal milieu were imprinted and thus
irreversible. To do so, we examined the expression of CEACAM1-S isoforms associated
with CD3+ T cells obtained from colonic LP before and after two weeks of ex vivo culture
with concanavalin-A and IL-2. These studies showed that dominant expression of
CEACAM1-S isoforms was lost under such conditions (Figure 1F) and demonstrate that the
L:S ratio observed within intestinal tissues is determined by, and requires continuous
exposure to, the relevant mucosal factors. Considering that CEACAM1-S expression
predominated in colon LP T cells from germ free Swiss Webster and C57BL/6 mice (Figure
S1E and S1F), Myd88−/− (Figure S1G) and Nod2−/− (Figure S1H) mice, the factors
responsible for this phenotype were neither dependent upon the presence of commensal
microbiota nor microbial-induced signaling.
The alternative splicing of CEACAM1 depends upon regulatory cis-acting elements within
exon 7 and flanking introns (Dery et al., 2011). Recently, the trans-acting auxiliary splicing
factors heterogeneous nuclear ribonucleoprotein (hnRNP) L, hnRNP A1 and hnRNP M
variants were shown to associate with exon 7 of the CEACAM1 mRNA and control splice-
site recognition motifs giving rise to CEACAM1-L or CEACAM1-S isoforms. Specifically,
whereas hnRNP A1 or hnRNP L promote CEACAM1-S isoform processing, hnRNP M
fosters the generation of CEACAM1-L isoforms (Dery et al., 2011). We therefore examined
whether the preferential expression of CEACAM1-S isoforms observed in the intestinal T
cells correlated with the appropriate profile of hnRNP expression as determined by qPCR.
Indeed, the expression of hnRNP A1 (Figure S1I) was higher and the expression hnRNP M
(Figure S1J) lower in T cells from PP in comparison to that observed in spleen and MLN.
As such, the hnRNP A1:hnRNP M ratio gradually increased in T cells isolated from spleen,
MLN and PP consistent with the increased amounts of CEACAM1-S relative to
CEACAM1-L in the intestine-associated tissues (Figure S1K). Together, these studies
indicated that the tissue-associated microenvironment of the intestine was uniquely
promoting CEACAM1 splicing which resulted in predominant CEACAM1-S expression.
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CEACAM1-4S functions as an independent signaling unit in the induction of T cell
activation
Although CEACAM1-L isoform expression in T cells is well-known to provide important
negative regulation of TCR-CD3 complex function after ITIM phosphorylation by the src-
related kinase, p56lck, and recruitment of SHP1 resulting in deposphorylation of CD3-ζ and
ZAP70 (Chen et al., 2008), very little is known about CEACAM1-S function in general or in
T cells in particular. Results in T cells are limited to transfected in vitro model systems and
remain controversial with both stimulatory and inhibitory functions assigned to CEACAM1-
S splice variants (Chen et al., 2004a; Chen et al., 2004b). Given the impossibility of
generating a mouse specifically lacking the CEACAM1-S splice variant without also
deleting the alternative CEACAM1-L variant, we generated CEACAM1-4S (4S) transgenic
(Tg) mice, overexpressing the mouse 4S isoform specifically in T cells under the human
CD2 (hCD2) promoter in order to explore the function of CEACAM1-S isoforms in T cells
in vivo. The overexpression of 4S in T cells was confirmed by flow cytometry using the
CC1 mAb. These studies confirmed that the T cells in the 4S Tg mice uniformly expressed
increased CEACAM1 (Figure S2A) with a predominance of CEACAM1-S isoforms (Figure
S2B).
When examined by flow cytometry, 4S Tg mice exhibited greater quantities of activated
CD4+ and CD8+ T cells as shown by lower percentages of CD62LhiCD44lo naïve T cells,
and a higher percentage of CD62LloCD44hi or CD62LhiCD44hi cells consistent with effector
memory and potentially central memory T cells (Seder et al., 2003) respectively, in spleen
(Figure 2A), MLN, PP and colon LP (Figure S2C). We also noted that 4S Tg mice exhibited
increased numbers of apoptotic CD3+ T cells (annexin V+7-AAD−CD3+ cells) within the
peripheral blood, spleen, MLN and PP (Figure 2B) which correlated inversely with
decreased quantities of CD3+ cells (Figure 2C). In spite of this, total PP and MLN cell
counts were found to be very similar between WT and CEACAM1-4S Tg mice (Figure
S2D) indicating that overexpression of CEACAM1-4S was selectively depleting T cells.
Intracellular cytokine staining of the CD4+ T cells isolated from spleen, MLN and PP also
revealed that IL-2, IL-4, IL-10, IL-17, IFN-γ and TGF-β were all increased in the T cells of
4S Tg mice when compared to that observed in WT littermates (Figure S2E). As illustrated
in Figure S2F for IFNγ, CEACAM1-S induction of cytokines influenced the total CD4+ T
cell population consistent with a broad activating function of the 4S isoform when highly
expressed. CD3+ T cells isolated from the spleen of 4S Tg mice also exhibited a higher
proliferation rate (Figure 2D) and more IFN-γ (Figure 2E) and IL-2 (Figure 2F) secretion
upon anti-CD3 stimulation ex vivo in comparison to that associated with T cells from WT
littermate controls. However, with longer time-periods of culture, the proliferation rate of
splenic CD3+ T cells from the 4S Tg mice was observed to be lower than that detected with
the WT littermates after stimulation, consistent with in vitro T cell contraction due to
increased activation-induced cell death (AICD) in the presence of the 4S isoform (Figure
2G). Consistent with this, splenic 4S Tg T cells exhibited increased annexin V staining
(Figure 2H) and cleavage of caspase 3 (Figure 2I) after 3 hours of anti-CD3 stimulation.
These results show that the mouse 4S isoform both co-stimulated primary T cells and
sensitized them to AICD, supporting previous in vitro transfection studies which ascribe
activating functions to this CEACAM1 isoform in contrast to the inhibitory functions of the
L isoform (Chen et al., 2004a; Chen et al., 2004b). Moreover, these observations further
supported the idea that both the increased total CEACAM1 expression and the enrichment of
the activating S isoform observed on T cells in intestinal tissues are associated with the
effector memory T cell phenotype which predominates in the normal intestinal LP under
steady-state conditions (Hurst et al., 1999).
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The activating function of CEACAM1-4S in T cells is observed independently of CEACAM1-
L isoform expression
Because the studies we performed in 4S Tg mice were undertaken in the context of
endogenous CEACAM1 expression, it was possible that the apparent activating and
inhibiting functions of the 4S isoform were either the consequence of CEACAM1-mediated
neutralization of CEACAM1-L inhibitory function and/or the result of a direct activating
signal by CEACAM1-S. To examine this question, we generated 4S Tg mice that lacked
expression of any other CEACAM1 isoforms by crossing 4S Tg mice with Ceacam1−/− mice
on a C57BL/6 background (Ceacam1−/−-4S Tg). Although less than that observed in 4S Tg
T cells containing endogenous amounts of CEACAM1 in all cell types, Ceacam1−/−-4S Tg
mice still contained more activated T cells in vivo as revealed by lower percentages of
CD4+(or CD8+) CD62LhiCD44lo naïve T cells, and higher percentages of CD4+(or CD8+)
CD62LloCD44hi effector memory T cells in spleen (Figure 2J), MLN, PP and colon LP
(Figure S2G) in comparison to Ceacam1−/− littermates. Ceacam1−/−-4S Tg mice also
exhibited more apoptotic CD3+ T cells within the MLN, blood and PP (Figure 2K) inversely
correlating with a decrease in CD3+ cells (Figure 2L). CD4+ T cells isolated from the
spleens of Ceacam1−/−-4S Tg mice also proliferated more vigorously (Figure 2M) and
secreted more IL-2 (Figure 2N) and IFN-γ (Figure 2O) upon anti-CD3 stimulation. Notably,
splenic CD4+ T cells from Ceacam1−/− mice exhibited increased activation upon anti-CD3
stimulation that was intermediate to the anti-CD3 induced stimulation observed with WT
and Ceacam1−/−-4S Tg T cells (Figure 2M–O). On the other hand, splenic T cells from mice
in which only the CEACAM1-4L (4L) isoform was expressed by T cells, generated by
crossing previously established 4L Tg mice (Nagaishi et al., 2006) with Ceacam1−/− mice,
exhibited a blunted response to anti-CD3 stimulation which was less than that observed with
WT T cells and is consistent with the inhibitory functions of this isoform (Figure 2M–O).
Taken together, these studies showed that loss of dominant endogenous CEACAM1-L
inhibitory function in Ceacam1−/− mice or gain of CEACAM1-S expression independently
of CEACAM1-L isoforms, as observed in Ceacam1−/−-4S Tg T cells, resulted in enhanced
TCR-CD3 complex signaling. In comparison, gain of CEACAM1-L isoforms independently
of CEACAM1-S isoforms led to inhibition of T cell function. Thus CEACAM1-S and
CEACAM1-L were able to function as independent activating and inhibitory signaling units
in T cells. Moreover, the blunted effects of CEACAM1 overexpression on T cells in vivo in
the absence of CEACAM1 expression elsewhere (Figures 2J–L) not only highlights the
importance of homophilic interactions presumably in trans with CEACAM1 on non-T cells
but also suggests a possible role for other heterophilic ligands in CEACAM1 activation.
CEACAM1-4S isoform function is associated with NFAT signaling
The studies described above suggested that CEACAM1-S isoforms possess direct signaling
functions in T cells. However, the mechanisms by which this might occur are unknown. To
clarify the possible signaling pathways involved in the functions observed as a consequence
of CEACAM1-4S expression on primary T cells, we performed Affymetrix cDNA
microarray analysis on primary CD4+ T cells isolated from MLN of WT or 4S Tg mice and
compared their transcriptional profiles. By doing so, we identified an elevation of a number
of genes associated with the Ca++- nuclear factor of activation (NFAT) signaling pathway
(Hermann-Kleiter et al., 2010) (Table S1). These included cytokines such as IFN-γ, IL-2
and IL-4 and cell surface proteins such as CD40L.
We therefore assessed NFAT expression and its intracellular distribution in primary CD4+ T
cells from the MLN of WT, 4S Tg, Ceacam1−/− and Ceacam1−/−-4S Tg mice. The most
important finding was that CD4+ T cells from 4S Tg or Ceacam1−/−-4S Tg mice exhibited
an obvious increase in the quantities of intranuclear NFAT relative to the amounts observed
in the T cells from their WT or Ceacam1−/− littermate controls, respectively, as defined by
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immunoblotting with an NFAT1 specific antibody in the setting of similar amounts of
intranuclear β-actin (Figure 3A and 3B). These biochemical studies were confirmed by the
morphological examination of tissues from 4S Tg mice (Figure 3C) which revealed
increased intranuclear accumulation of NFAT in CD4+ T cells within the PP of 4S Tg mice
in comparison to that observed in the PP of WT littermate controls (Figure 3C). These
studies confirmed the activating function of the 4S isoform and suggest that CEACAM1-S-
mediated activation of T cells involves NFAT.
CEACAM1-4S on T cells regulates Peyer’s patches and the generation of IgA-dependent
secretory immunity
Given the relative importance observed for CEACAM1-S isoforms in T cells within
intestinal tissues, including their enrichment in the S isoform and increased expression of
NFAT-dependent factors such as CD40L, we next sought to determine whether the functions
associated with CEACAM1-S-mediated signaling were linked to normal physiologic
operations within the intestines. We first observed that, despite being present in equal
numbers (Figure 4A), PP of 4S Tg small intestine were considerably larger in size than those
of their WT counterparts (Figure 4B). Using a previously published scoring system which
takes into account both PP frequency and size (Barreau et al., 2007), we determined that the
total surface area occupied by PP of 4S Tg small intestine was substantially greater than that
associated with their WT counterparts (Figure 4C). Since similar observations were made
when Ceacam1−/−-4S Tg mice were compared to Ceacam1−/− littermate controls (Figure
4D), these observations provided evidence that enlarged PP size was a direct consequence of
CEACAM1-S function.
We therefore next examined B cell development in the PP of WT and 4S Tg mice. As shown
in Figure 4E (and Table S2), we detected increased B220−IgA+ cells resembling activated
plasma cells by flow cytometry in the PP and LP of 4S Tg mice relative to WT littermate
controls. Consistent with this, the proportion of B220−IgA+ cells was decreased in the PP of
Ceacam1−/− mice relative to their WT littermate controls (Figure 4F and data not shown).
Using immunofluorescence microscopy, we confirmed the specific localization of these
plasma cells in the PP of WT and 4S Tg mice (Figure 4G). In contrast, no differences were
seen in the frequency of B220+IgA+ cells in either the PP or LP of WT and 4S Tg mice
(Table S2). These studies showed that the PP of 4S Tg exhibited an increase in activated,
IgA-committed plasma cells and that Ceacam1−/− mice demonstrated a corollary decrease in
such cells, thereby confirming the physiological requirement for CEACAM1-S in
establishing an adequate plasma cell distribution in the intestine.
We then examined the functional consequences of CEACAM1-4S in T cells on gut B cells
by studying the immunoglobulin content of the intestinal secretions from 4S Tg and
Ceacam1−/− mice. These studies revealed that the quantity of secreted IgA correlated with
CEACAM1-4S expression in that lumenal IgA, but not IgG, was increased in 4S Tg mice
and decreased in Ceacam1−/− mice relative to WT littermate controls (Figure 4H).
Interestingly, although there were no significant differences in the serum IgA concentration
observed in WT and Ceacam1−/− animals, there was a slight trend toward an increase in
serum IgA, but not IgG concentrations, in 4S Tg mice compared to WT littermate controls
(Figure 4I). Together, these data revealed that CEACAM1-S led to increases in both the
quantity and activity of IgA+ plasma cells in intestinal tissues, enlarging the size of PP and
enhancing secretory immunity.
CEACAM1 regulates mucosal defense to oral Listeria monocytogenes infection
We next determined whether the physiological role of CEACAM1 in regulating PP-
mediated secretory immunity through CEACAM1-S expression extended to defense against
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a mucosal pathogen. In this regard, we chose to study Listeria monocytogenes, a Gram-
positive intracellular pathogen, since previous studies indicate that Ceacam1−/− mice are
susceptible to an intraperitoneal challenge with L. monocytogenes (Pan et al., 2010) and
secretory immunity is likely to play an important role in immune defense against this
bacterial pathogen (Manohar et al., 2001). We therefore examined the responses of
Ceacam1−/− mice, 4S Tg mice and their WT littermates to oral infection with L.
monocytogenes. 72 hours after induction of infection, the bacterial burden in both
Ceacam1−/− small intestine and liver were substantially higher than that in WT and 4S Tg
mice. Specifically, a 1000-fold increase in colony forming units (c.f.u.) of L.
monocytogenes was detected in the small intestine of Ceacam1−/− mice and a 100-fold
increase in c.f.u. of L. monocytogenes was observed in the liver of Ceacam1−/− mice
compared to WT or 4S Tg mice, while no statistically significant difference was observed in
the spleen for any group (Figure 4J). Conversely, the number of L. monocytogenes
recovered from the small intestine, liver and spleen of 4S Tg mice was decreased relative to
that observed in WT mice (Figure 4J). It is also notable that the quantity of secretory IgA
detected in the small intestinal secretions of 4S Tg mice challenged with L. monocytogenes
was greatly increased relative to that observed in WT mice (Figure 4K). Consistent with this
observation, the unrestrained L. monocytogenes infection identified in Ceacam1−/− mice
was associated with decreased secretion of intestinal IgA and increased IgA concentration in
the serum of Ceacam1−/− mice in response to infection (Figure 4K). These data
demonstrated that CEACAM1, and particularly CEACAM1-S, was necessary for an optimal
response to mucosal challenge with a bacterial pathogen and that this was mediated through
CEACAM1-dependent regulation of intestinal IgA secretion.
Overexpression or loss of CEACAM1-S on T cells alters the composition of the commensal
microbiota
The studies above showed that a normal physiologic function of CEACAM1 in mucosal
tissues is promoting secretory immunity in the PP and that this process is capable of
enhancing protection against intestinal pathogens. Since IgA is a major regulator of the
commensal microbiota (Macpherson et al., 2001), we hypothesized that forced expression of
CEACAM1-S on T cells, as observed in 4S Tg mice, or loss of CEACAM1 expression, as
observed in Ceacam1−/− mice, and which lead to increased and decreased IgA
concentrations in the secretions, respectively, might result in demonstrable changes in the
composition of the commensal microbiota in the ileum, the predominant site of the anatomic
changes observed.
We therefore used quantitative culture methods to assess the composition of the commensal
microbiota in the ileum from groups of age, gender and strain matched WT, 4S Tg and
Ceacam1−/− mice. Culture of full-thickness bowel and of luminal contents is used as a
means for evaluation of predominant species found in the gut and provides a normalized
assessment of microbial biomass relative to the input mass of full thickness segments of
terminal ileum (Bjorneklett et al., 1983). Culture-based studies are also leveraged to identify
individual species and communities of bacteria that play an essential role in eliciting host
phenotypes (Baumgart et al., 2007). Using aerobic and anaerobic culture techniques and
selective and differential media, as described in Supplementary Methods, we recovered nine
distinct isolates from the ileum of 4S Tg and WT mice (Table 1 and Table S3). These
isolates spanned three orders, Lactobacillales, Bacillales and Bacteroidales, with 55% of
isolates belonging to the genus Lactobacillus. The microbial diversity of the samples from
4S Tg mice was significantly higher than that of littermate WT controls, as assessed by
multiple ecological measures of diversity (Table 1 and Table S3). In addition, certain
isolates were substantially more abundant in the 4S Tg mice as compared to WT controls,
including Gemella morbillorum, Lactobacillus murinus and Lactobacillus acidophilus. For
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Ceacam1−/− mice, we recovered ten distinct isolates spanning five orders, including those
found in 4S Tg mice, and additionally the orders Clostridiales and Bifodobacteriales (Table
1 and Table S3). Microbial diversity of the samples from Ceacam1−/− mice was also
considerably higher than that of controls, but only one isolate, Lactobacillus brevis, was
found to be more abundant in Ceacam1−/− mice (Table 1). These studies showed that, as
would be predicted by the observed increased and decreased IgA secretion (Fagarasan,
2008; Macpherson et al., 2004) in 4S Tg and Ceacam1−/− mice, respectively, the
composition of the commensal microbiota was regulated by CEACAM1.
CEACAM1 is preferentially expressed on specific subsets of circulating and tissue-
resident CD4+ T cells
Given our observations concerning the impact of CEACAM1 on the regulation of secretory
IgA and its consequences in T cell-targeted 4S Tg mice as well as the known importance of
T cells to B cell development, we sought to define the subsets of CEACAM1-regulated T
cells responsible for these activities. To do so, we focused our attention on defining the
accessory molecules expressed by the small subset of CEACAM1+ T cells detected under
physiologic conditions in spleen and MLN and which were increased in frequency in PP and
LP in WT mice (see Figure 1A). We observed that CD4+CEACAM1+ T cells from the
blood, MLN, PP and LP expressed higher amounts of both CD44 and CD62L than did
CD4+CEACAM1− T cells (Figure 5A and S3A–C). This is consistent with CEACAM1
being associated with effector and/or central memory T cells (Boulton et al., 2002).
Additionally, we noted that CD4+CEACAM1+ T cells from each of these tissue
compartments expressed more α4β7-integrin than their CD4+CEACAM1− counterparts,
suggesting that CEACAM1 expression on T cells, even those within the peripheral immune
system, is associated with enhanced potential to home to intestinal tissues. Interestingly, we
also noted that CEACAM1 positivity was associated with preferential expression of PD-1,
LAP (TGFβ Latency Associated Peptide) and B220, all of which are characteristics
associated with T cell subsets possessing regulatory or accessory potential in the production
of IgA (Fagarasan et al., 2001; Good-Jacobson et al., 2010; Ochi et al., 2006; Oida et al.,
2003).
These observations led us to next focus on specific cell subsets on which the identified
molecules are known to be enriched. In particular, since our data showed CEACAM1
expression to be strongly co-segregating with surface LAP on CD4+ T cells from naïve WT
animals (Figures 5A and S3A–C), we carefully examined CD4+CD25−LAP+ T cells, a
subset of Treg that are concentrated in intestinal tissues and provide TGF–β dependent
regulatory function and, potentially, support for secretory IgA immunity (Niemir et al.,
1995; Ochi et al., 2006; Oida et al., 2003). Whereas on average 43.6 ± 10.9 % of
CD4+CD25−LAP+ T cells within MLN co-expressed CEACAM1, only 2.07 ± 0.8 % of
CD4+CD25−LAP− cells were also CEACAM1+ under steady-state conditions in WT mice
(Figure 5B). This was in stark contrast to the CEACAM1 expression in another regulatory T
cell subset wherein similar low quantities of CEACAM1 were observed on CD4+Foxp3+
and CD4+Foxp3− Treg cells from the MLN (Figure 5B). We next examined the relative
expression of the CEACAM1-L and -S isoforms in CD4+CEACAM1−LAP−,
CD4+CEACAM1+LAP−, or CD4+CEACAM1+LAP+ cells flow-cytometrically sorted from
pooled spleen and MLN of WT mice using the real-time PCR assay described above
(Figures S1A–B). Consistent with our findings in the total population of peripheral CD4+ T
cells, the ratio of L:S isoforms was 2.78 ± 0.07 in CD4+CEACAM1+LAP− cells, indicating
a predominance of the L isoform in this group of T cells (Figure 5C). In contrast, the L:S
ratio was decreased to 1.16 ± 0.27 (P < 0.05) in CD4+CEACAM1+LAP+ cells indicating an
enrichment of the CEACAM1-S isoform in this regulatory cell subset (Figure 5C). No
differences were observed in the L:S ratio between CD4+CEACAM1+CD25− cells (1.52 ±
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0.29) and CD4+CEACAM1+CD25+ cells (1.52 ± 0.11) isolated from the spleen and LN
(Figure S3D). These data demonstrated the existence of a close association between the
expression of CEACAM1 and LAP.
The preferential expression of PD-1 noted on CD4+CEACAM1+ T cells further led us to
investigate a subset of T cells on which this molecule is enriched. High expression of PD-1
is associated with T follicular helper (Tfh) cells which regulate the formation of long-lived
plasma cells by driving the survival and selection of B cells in mature germinal centers
(Good-Jacobson et al., 2010). In addition to PD-1, Tfh cells are identified by high
expression of CXCR5 (Linterman et al., 2011) and upon investigation, we observed that
CD4+CEACAM1+ T cells from both the spleen and MLN of WT mice are enriched in
expression of this chemokine receptor compared to their CD4+CEACAM1− counterparts
(Figure 5D). Thus, our data indicated that Tfh cells preferentially expressed CEACAM1
under physiological conditions. A deeper investigation of the CEACAM1 isoforms
expressed by PD-1+CXCR5+ Tfh cells also revealed an enrichment of CEACAM1-S
isoforms in Tfh cells from the spleen, PP and MLN (Figure S3E). Specifically, in contrast to
the majority of peripheral CD4+ T cells, which predominantly express CEACAM1-L
isoforms, Tfh cells expressed near equal amounts of CEACAM1-L and CEACAM1-S
(Figure S3E). Collectively, these data provided evidence that high expression of
CEACAM1, and in particular enrichment of CEACAM1-S, was a defining feature of certain
subsets of CD4+ T cells under physiological conditions which serve a regulatory or
accessory role in secretory immunity and preferentially localize to organized lymphoid
structures and/or intestinal tissues.
CEACAM1-S independently regulates the expansion and function of CD4+ T cells in which
it is enriched
Our observations of preferential CEACAM1 expression on CD4+CD25−LAP+ and Tfh cells
from WT mice led us to question the ability of CEACAM1 to regulate these cells and,
further, to interrogate the relative contribution of CEACAM1-L and CEACAM1-S isoforms
in this process. Utilizing the CEACAM1 transgenic mice, we first examined the frequency
of CD4+CD25−LAP+ T cells in mucosal tissues under conditions of forced overexpression
of the CEACAM1-4L or -4S isoforms. These data demonstrated a significant increase in the
percentage of CD4+CD25−LAP+ T cells in the MLN from 4S Tg mice relative to WT
controls (Figure 6A and B) and in Ceacam1−/−-4S Tg mice compared to Ceacam1−/−
controls (Figure 6C and D). This increase in CD4+CD25−LAP+ cells was specifically
detected under conditions of overexpression of the CEACAM1-4S isoform in both WT and
Ceacam1−/− animals (Figure 6A and C) and was notably absent in CEACAM1-4L
transgenic mice in which the inhibitory CEACAM1 isoform was overexpressed (Figure 6B
and D). Given the detected increases in cell death in both CD4+LAP− and CD4+LAP+
populations in 4S Tg animals (Figure S4A), our finding of an expanded population of viable
CD4+LAP+ T cells under conditions of CEACAM1S overexpression can best be explained
not by decreased AICD amongst this population but rather by increased generation of the
CD4+LAP+ T cells in the presence of forced CEACAM1-4S expression. In stark contrast,
our analysis did not reveal any differences in the frequency of CD4+CD25+Foxp3+ T cells
upon forced expression of CEACAM1-4S in T cells relative to that observed in WT mice
(data not shown), In order to ascertain whether enrichment of activating CEACAM1-S was
functionally relevant to CD4+CD25−LAP+ T cells, we examined the in vitro suppressive
function of CD4+LAP+ T regulatory cells obtained from the MLN of 4S Tg mice. We found
that these cells possessed enhanced regulatory activity when compared to CD4+CD25−LAP+
T cells from WT controls (Figure 6E). In contrast, no differences were observed in the
regulatory potential between 4S Tg and WT CD4+CD25+ Treg cells obtained from the MLN
in similar assays (Figure 6E). Taken together, these studies indicated that the relative
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increase of CEACAM1-4S, in the absence of any contribution from the inhibitory
CEACAM1-L isoforms, specifically enhanced both the development and functional capacity
of regulatory CD4+CD25−LAP+ T cells.
It is known that CD4+CD25−LAP+ T cells accumulate in intestinal tissues under steady-state
and inflammatory conditions and that orally administered CD3-specific antibodies induce
CD4+CD25–LAP+ regulatory T cells in MLN (Boirivant et al., 2008; Ochi et al., 2006). We
thus made use of this approach in order to determine whether CEACAM1 is specifically
involved in the induction phase of CD4+CD25–LAP+ T cell development under conditions
of physiological CEACAM1 expression. While no significant differences were identified in
the proportions of CD3+CD25+/−LAP+ Treg cells in spleen, MLN, PP or blood of untreated
or isotype-treated Ceacam1−/− and WT mice, oral administration of anti-CD3 antibody
substantially increased the percentage of CD4+CD25−LAP+ T cells in the MLN of WT but
not Ceacam1−/− mice (Figure 6F). In contrast, oral administration of a CD3-specific
antibody was not observed to alter the percentage of CD4+Foxp3+ T regulatory cells in the
MLN of WT or Ceacam1−/− mice (Figure S4B). These studies confirmed a physiological
role played by CEACAM1 in regulating the expansion of CD4+CD25−LAP+ T cells in
mucosal tissues as well as in promoting their suppressive function.
Given our observation of PP enlargement in 4S Tg mice and the preferential expression of
CEACAM1-S in Tfh cells in WT mice, we next examined the impact of highly abundant of
CEACAM1-4S on the frequency of Tfh cells in the spleen, MLN and PP of 4S Tg mice.
Flow cytometric analysis of each of these tissues revealed an enrichment not only of PD-1
itself (Figure S4C) but also of the PD-1+CXCR5+ population of Tfh cells in the 4S Tg mice
compared to their WT littermate controls (Figure 6G). Importantly, CEACAM1-4S-
mediated enrichment of Tfh cells occurred completely independently of the CEACAM1-4L
isoform since Ceacam1−/−-4S Tg mice also contained much higher amounts of Tfh cells
than their Ceacam1−/− counterparts (Figure 6H). Collectively, our data are consistent with a
role for CEACAM1-S isoforms in promoting the development of two types of accessory
cells (CD4+CD25−LAP+ cells and Tfh cells) which are not only enriched in organized
lymphoid structures and mucosal tissues but are also known to be involved in B cell
activation (Cerutti, 2008; Good-Jacobson et al.), and likely thus contribute to the ability of
CEACAM1 to regulate secretory intestinal immunity.
Discussion
Here, we provide evidence for tissue and cell-type specific regulation of CEACAM1
splicing in T cells which results in the unique predominance of CEACAM1-S isoforms in
intestinal resident T cells and specific subsets of T cells associated with humoral immunity.
Although CEACAM1 is an activation-induced molecule on T cells, the observed tissue-
specific splicing was not due to activation of the T cells per se as it was not observed when
T cells were stimulated ex vivo. Adoptive transfer experiments demonstrated that
CEACAM1-S dominance was gained by naïve peripheral T cells upon entry into the
intestines, and was lost when mucosal T cells were removed from the intestines and re-
stimulated ex vivo. This indicated that the specific mucosal milieu of the intestines promotes
CEACAM1-S expression in T cells. Moreover, our results in 4S Tg mice indicated that
CEACAM1-S facilitates T cell activation and the induction of secretory IgA immunity.
Consistent with this, T cell subsets which bore a memory phenotype characteristic of
mucosal tissues (Gibbons et al., 2011) and specific subsets of T cells such as
CD4+CD25−LAP+ and Tfh cells which encourage secretory immunity displayed an
enrichment upon CEACAM1-S expression and were driven by its presence. Thus,
CEACAM1-S expression is promoted and maintained by the mucosal environment and
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facilitates T cell activation linked to the generation of cell types responsible for mucosal
regulation and protection.
The mucosal factors responsible for this preferential splicing within the mucosal
microenvironment of the intestines are unknown. We showed that the differential splicing of
CEACAM1 occurred independently of microbial factors, as observed in GF mice, and
related signaling pathways such as MyD88 and NOD2. This suggests that microbial-
independent tissue-specific factors and their own related pathways regulate CEACAM1
splicing and expression in the intestines. Whether these factors include soluble (e.g.
cytokines) or cell surface molecules unique to the mucosal tissues, it is clear that they
regulate both the extent of CEACAM1 expression and the splicing of its mRNA. These
studies also demonstrated that tissue- and cell-specific regulation of Ceacam1 alternative
splicing occurs in vivo and is linked to specific immune functions.
Importantly, these studies also showed that CEACAM1-S is not a minor isoform in primary
T cells as was currently thought (Gray-Owen et al., 2006). In transgenic mice with
conditional expression of CEACAM1 in T cells, we found that CEACAM1-S provided
unique co-stimulatory signals which promoted both AICD and an effector memory
phenotype, whereas CEACAM1-L was co-inhibitory for TCR-CD3 complex signaling
(Nagaishi et al., 2006). Moreover, we have now shown that CEACAM1-S in T cells can
elicit this stimulation as an independent signaling unit without CEACAM1-L assistance in
vivo. Through these properties, CEACAM1-S regulates specific subsets of T cells. These
cell populations include CD4+LAP+ T cells and Tfh cells which are an integral component
of mucosal tissues and organized lymphoid structures, respectively, and are known to
regulate secretory immunity (Linterman et al., 2011). In view of CEACAM1-S enrichment
in these latter cell types irrespective of their localization to peripheral or mucosal tissues as
well as with our observations that the intestinal tissues facilitate CEACAM1-S expression,
our studies also raise that possibility that CD4+LAP+ T cells and Tfh cells may be born in
and/or modified remotely by mucosal factors.
Although little is known about CEACAM1-S signaling in T cells, in epithelial cells it is
known to associate with the cytoskeleton (actin and tropomyosin), calmodulin and annexin
II (Edlund et al., 1996; Kirshner et al., 2003; Schumann et al., 2001). Such intracellular
associations, interestingly, are linked to the promotion of apoptosis of mammary epithelial
cells during acini morphogenesis (Kirshner et al., 2003), In addition, consistent with
previous transfection studies in Jurkat T cells, CEACAM1-S signaling is able to activate
NFAT in vivo (Chen et al., 2004b). As shown here, this was associated with the
upregulation of NFAT-dependent soluble and cell surface molecules such as PD-1 and
CD40L. Thus the current studies not only demonstrated the importance of CEACAM1-S in
T cells under physiological conditions but also their role in delivering independent signals
that may oppose those provided by CEACAM1-L isoforms. Such observations further
highlight the functional similarities between CEACAM1 and other signaling pathways that
comprise highly related activating and inhibiting modules such as CD28 and CTLA-4
(Greenwald et al., 2005).
Presumably through its NFAT-related activation functions, CEACAM1-S-mediated T cell
activation of B cells in the PP promoted the generation of IgA plasma blasts, the expansion
of PP size and IgA secretion into the lumen. Given the decreases in IgA secretion observed
in the absence of CEACAM1 expression and increased IgA secretion when CEACAM1-4S
is overexpressed on T cells, CEACAM1-S in T cells emerges as an important factor in
directly regulating B cell function and PP structure. PP are the essential inductive sites for
regulation of antigen-specific IgA antibody responses following oral immunization,
although a PP-independent pathway for mucosal IgA responses also likely exists
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(Macpherson et al., 2007; Cerutti, 2008; Hashizume et al., 2008). Previous show that
selective TGF-β receptor type II deficiency in B cells results in loss of IgA-expressing cells
in the spleen and PP (Borsutzky et al., 2004; Cazac et al., 2000). Consistent with this,
CD4+CD25+ Tregs have been identified as major helper cells for IgA responses to microbial
antigens such as flagellin, presumably through their secretion of TGF-β (Cong et al., 2009).
As CD4+CD25−LAP+ T regulatory cells are also TGF-β-dependent (Ochi et al., 2006; Oida
et al., 2003), were increased in the mucosal tissues of mice that overexpress CEACAM1-4S
and inadequately expanded by T cell receptor-dependent signals in the absence of
CEACAM1 expression, a plausible mechanistic explanation for the increased IgA
production and TGF-β secretion observed in 4S Tg mice is that CD4+CD25−LAP+ T cells
are a responsible factor. Additionally, the increased frequency of PD-1+CXCR5+ Tfh cells
which we observed in the spleen, MLN and PP of 4S Tg mice is likely to provide additional
stimulation to IgA-producing plasma blasts since CXCR5+ Tfh cells in B cell zones of
lymphoid tissues possess significant capacity for supporting IgG and IgA production by B
cells (Fazilleau et al., 2009a). The ability of Tfh cells to regulate antigen-specific B cell
immunity in vivo is likely linked to its high expression of PD-1, which is NFAT dependent
(Oestreich et al., 2008) and is known to deliver signals that promote long-lived plasma cell
responses (Good-Jacobson et al., 2010). Thus, our studies showed that CEACAM1-S
regulates secretory IgA within PP via its ability to elicit NFAT-mediated signaling which
enhances the expression of cell surface molecules such as CD40L and PD-1, the expansion
of CD4+CD25−LAP+ T cells and Tfh cells and the secretion of TGF-β, IL-2, IL-4 and IL-10
by CD4+ T cells; all factors which promote secretory IgA immunity (Cazac et al., 2000;
Cerutti, 2008; Good-Jacobson et al., 2010; Massacand et al., 2008). As a consequence, in the
absence of CEACAM1, secretory IgA is reduced.
The ability of CEACAM1 to regulate secretory IgA production is also interesting given the
well-known role of CEACAM1 as a microbial receptor (Gray-Owen et al., 2006). Moreover,
bacteria are well-known inducers of secretory IgA production (Macpherson et al., 2004) and
IgA in turn regulates the composition of the commensal microbiota (Fagarasan, 2008). For
example, IgA concentrations are very low in GF animals with normalization of these
amounts within a few weeks following intestinal bacterial colonization after birth
(Hapfelmeier et al., 2010). IgA-deficiency is also associated with a bloom in certain
organisms in the intestinal lumen (Suzuki et al., 2004). Furthermore, secretory IgA promotes
both immune exclusion and neutralization of translocated bacteria which preserves intestinal
barrier integrity by preventing bacterial-induced inflammation (Boullier et al., 2009). In
addition, IgA can promote bacterial colonization as shown for Helicobacter sp. which bind
to the gastric epithelium via IgA but do not invade (Taylor et al., 2007). As such, IgA can
contribute to the survival of certain classes of bacteria within the intestines. The latter is also
consistent with the ability of secreted IgA to bind to luminal bacteria (van der Waaij et al.,
1996) and in some cases inhibit their invasiveness, as observed during Salmonella
typhimurium infection (Wijburg et al., 2006). Consistent with this, we observed that
CEACAM1 gain-of-function in T cells and loss-of-function correlated with the ability of the
host to resist the pathogenicity of L. monocytogenes infection. Ceacam1−/− and 4S Tg mice
also demonstrated increased community diversity of the commensal ileal microbiota, with a
predominance of Lactobacillus and Streptococcus species as compared to WT controls. This
indicated that CEACAM1-S dependent effector functions of these T cells have the capacity
to modulate the composition of microbial communities in the small intestine, presumably
through their effects on IgA secretion. These observations not only further support a role for
CEACAM1 in the generation of secretory immunity but show that it is physiologically
important to the regulation and control of the intestinal microbiota and enteropathogens.
In summary, our studies have shown that in tissue resident T cells of the intestines as well as
in specific subsets of T cells, not only are CEACAM1-S isoforms expressed, but they often
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dominate over CEACAM1-L isoforms. In these cells, CEACAM1-S provides unique signals
that promote populations of T cells regulating IgA production and secretion associated with
control of the commensal microbiota and resistance to enteropathogens. These studies
demonstrate the important role played by CEACAM1-S isoforms in immunity.
Experimental Procedures
Animals
Wild-type (WT) C57BL/6 (B6) mice were purchased from The Jackson Laboratory. hCD2
promoter controlled CEACAM1-4S transgenic mice were generated in the of Brigham and
Women’s Hospital Transgenic Core Facility by a similar strategy to that previously
described (Nagaishi et al., 2006). Ceacam1−/− mice were previously described (Leung et al.,
2006). Myd88−/− mice and Nod2−/− mice were kindly provided by Dr. S. Akira (Osaka,
Japan) and Dr. K. S. Kobayashi (Dana-Farber Cancer Institute, Boston, MA), respectively.
Swiss Webster germ-free (SWGF) mice and C57BL/6 germ-free mice (B6GF) were
maintained in germ-free isolators at Taconic. All other mice were maintained under specific
pathogen-free conditions at the Harvard Center for Comparative Medicine at Harvard
Medical School. All mice were used between 8 and 12 weeks of age. All animal
experimentation was performed in accordance with the Institutional Animal Care and Use
Committee (IACUC) of Harvard Medical School which granted permission for this study.
Flow Cytometry
For CEACAM1 expression assays, cells were incubated with the CC1 antibody for 20 min
followed by FITC-conjugated rat anti-mouse IgG1. For other cell surface proteins, cells
were stained with the indicated fluorescence-conjugated antibodies for 20 min, washed and
resuspended with 1% BSA/PBS FACS staining buffer containing DAPI (Invitrogen). Cell
apoptosis assays were performed according to the Annexin V-FITC Apoptosis Detection Kit
manual (BD Bioscience). For intracellular cytokine staining, cells were stimulated with
ionomycin (Sigma, 2 μg/ml), PMA (Sigma, 30 ng/ml) and Golgistop (BD Bioscience) for 4
hours followed by intracellular cytokine staining using Cytofix/Cytoperm solution kit
according to the manufacturer’s instructions (BD Bioscience). IgA staining was performed
according to the instructions provided with the rat anti-mouse IgA antibody (C10-3).
CD4+LAP+ T cells were stained for 20 min with biotinylated anti-LAP antibody (R&D
Systems) followed by APC-conjugated streptavidin (BD Biosciences) as described
previously (Ochi et al., 2006). Tfh cells were stained for CXCR5 and PD-1 as described
previously (Linterman et al., 2011). All stained cells were analyzed on an LSRII (BD
Biosciences) or a MACSQuant (Miltenyi Biotech) flow cytometer, and data were analyzed
using Flowjo software.
Culture-based studies of ileal microbial community structure
Samples of terminal ileum (2 cm from the ileocecal valve) were sterilely dissected from
mice, placed in cryovials and immediately snap frozen on liquid nitrogen. Samples were
delivered to the Harvard Digestive Disease Center’s (HDDC) Microbiome and Gnotobiotics
Core facility on dry ice and stored at −80°C until processing. Isola tion of microorganisms
and determination of microorganisms is described in the Supplementary Methods.
Oral Listeria monocytogenes Infection
Gender- and age-matched groups of Ceacam1−/− mice, 4S Tg mice and WT littermates were
housed under BL2 conditions prior to infection. Approximately 5×108 c.f.u. of a fourteen- to
sixteen-hour culture of L. monocytogenes strain InlAm (Wollert et al., 2007) was suspended
in 0.2 mL PBS. The suspension was delivered intragastrically to mice with a 21 gauge
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feeding needle attached to a 1 mL syringe. Animals were monitored daily and at 72 hours
post infection were sacrificed and dissected for histological analysis, IgA production and
determination of the number of bacteria present in the small intestine, spleen and liver. c.f.u.
assays (small intestine, spleen and liver c.f.u./organ) were performed as previously described
(Kaser et al., 2008).
Oral feeding of anti-CD3
Mice were fed with anti-CD3 antibody using a protocol described previously (Ochi et al.,
2006). Specifically, groups of paired mice were fed anti-CD3 or IgG isotype control
antibody at a dose of 5 μg/mouse/day for 5 days. After one day’s rest, mice were sacrificed
at day 7 and the percentage of CD4+LAP+ regulatory T cells was determined in specific
lymphoid tissues.
Suppression assays
Regulatory T cell suppression assays were performed as previously described (Fantini et al.,
2007). Briefly, 1×105 freshly isolated splenic CD4+CD25− T cells were stained with CFSE
and mixed with an equal number of either CD4+CD25+ or CD4+LAP+ T regulatory cells
isolated via magnetic sorting (Miltenyi). T cell mixtures were then activated in the presence
of soluble anti-CD3 (1 μg/ml) and 4×105 irradiated total splenocytes as antigen presenters.
After 4 days of culture, CFSE dilution of the responder CD4+CD25− T cells was measured
as an indication of proliferation.
Total Serum and secretion Immunoglobulin ELISA
The sera, intestinal washes or fecal extracts were collected for ELISA as previously
described (Hapfelmeier et al., 2010).
Immunohistochemical analysis
PP were isolated and embedded in OCT compound (Sakura Finetechnical) and snap frozen
in dry ice. Frozen sections were prepared on micro slides using a cryostat (Leica), and stored
at −70°C until use. The slides were fixed in 100% aceto ne for 5 min at 4°C and air dried at
room temperature. Cryostat sections were blocked with 10% normal goat serum for 1 hour at
room temperature (RT). For B220 and IgA staining, the slides were stained with purified rat
anti-mouse IgA antibody for 1 hour at RT, followed by incubation with Alexa Fluro 568
conjugated goat anti-rat IgG secondary antibody (Invitrogen) and FITC-conjugated anti-
mouse B220 antibody (BD Bioscience) for 1 hour at RT. For NFAT staining, the slides were
stained with biotin conjugated-anti-mouse CD4 antibody and rabbit anti-NFAT1 antibodies
for 2 hours at RT, followed by incubation with rhodamine red-X-streptavidin (Jackson
ImmunoResearch) and Alexa Fluor® 488 F(ab′)2 fragment of goat anti-rabbit IgG (H+L)
(Invitrogen) for 1 hour at RT. The counterstaining was performed using DAPI (Invitrogen).
The specimens were analyzed using a Nikon Eclipse Ti microscope.
Statistics
The Mann-Whitney U-test (two-tailed) was used to assess differences in log10 colony
forming units (c.f.u.) in quantitative culture assays. The t-test (two-tailed) was used to assess
differences between means for other data analyzed. Tests with a P-value less than 0.05 were
considered statistically significant. Data are presented as mean ± SD or ± SEM., as indicated
in the figure legend. Microbial diversity was assessed using two common ecological
measures of diversity, Shannon information entropy (Shannon, 1997) and Simpson’s
diversity index (Baumgart et al., 2007). Both measures take into account the abundances of
species relative to one another in a sample.
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Intestinal T cells predominantly express CEACAM1-S isoforms. (A) Cell surface expression
of CEACAM1 (CC1 antibody) on CD3+ T cells from spleen, MLN, PP or lamina propria
(LP) of colon from C57BL/6 mice. (B) qPCR for transcriptional analysis of CEACAM1-L
and -S in CD3+ T cells isolated from spleen, MLN, blood, PP or segments of small intestine
and colon LP from WT mice. (C) Cell surface expression of CEACAM1 (5F4 antibody) on
CD3+ T cells from human peripheral blood (PBMC) or colon LP. (D) Semi-quantification of
the relative transcription of CEACAM1-L and -S in human CD3+ T cells isolated from
peripheral blood with indicated treatment or from fresh colon LP. (E) qPCR for
quantification of CEACAM1-L and -S transcription in naïve CD3+ T cells from WT mice,
MLN T cells from WT mice and CD3+ T cells isolated from spleen and colon LP of Rag2−/−
mice adoptively transferred with WT CD4+ naïve T cells. (F) T cells isolated from mouse
LP were expanded with ConA and IL-2 in vitro for two weeks and the expression of
CEACAM1-L and -S were determined by qPCR.
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CEACAM1-4S is associated with activation of primary T cells. (A) Spleen cells were first
gated on CD3+ cells, and either CD4+ or CD8+ cells, and later examined for CD44 and
CD62L expression. 4S Tg mice possessed lower percentages of CD62LhiCD44low naïve T
cells and higher percentages of CD62LlowCD44hi effector memory T cells when compared
to that of WT mice. (B–C) Compared to WT littermates, 4S Tg mice exhibited higher
percentages of CD3+ Annexin V+/7AAD− apoptotic cells (B) and lower percentages of
CD3+ T cells (C) in various tissues. (n = 5 mice per group) (D–H) CD3+ T cells isolated
from the spleen of 4S Tg mice and their WT littermates were cultured with anti-CD3
antibody at indicated concentrations, or 1 μg/ml anti-CD3 over the indicated time course
(G). Proliferation assays were performed by [3H]-thymidine incorporation (D and G); IFNγ
(E) and IL-2 (F) production were measured by ELISA; and apoptosis was determined using
annexin-V and 7-AAD staining (H). (n = 5 mice per group) (I) CD3+ T cells were isolated
from the spleen of 4S Tg or WT mice, and cultured with IL-2 (100 U/ml) or anti-CD3 (1 μg/
ml) coated plates. Cell lysates were prepared at the indicated times, and caspase-3 and its
activated form were determined using immunoblot. (J–L) Compared to Ceacam1−/− mice,
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Ceacam1−/−-4S Tg mice have lower percentages of CD62LhiCD44low naïve T cells and
higher percentages of CD62LlowCD44hi effector memory T cells in the spleen (J), higher
percentages of annexin V+/7AAD− apoptotic cells (K) and lower percentages of CD3+ T
cells (L). (n = 5 mice per group) (M–O) T cells isolated from spleen of WT, Ceacam1−/−,
Ceacam1−/−-4S Tg (4S Tg/KO) or Ceacam1−/−-4L Tg (4L Tg/KO) mice were cultured with
anti-CD3 at the indicated concentrations and proliferation assays were performed by [3H]-
thymidine incorporation (M). IL-2 (N) and IFNγ (O) production were measured by ELISA.
(n=4 mice per group). All data are mean ± SEM; *, p < 0.05 (two-tailed Student’s t test), ND
= not detected.
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Overexpression of CEACAM1-4S on T cells enhances the nuclear translocation of NFAT1.
(A–B) Immunoblot of whole cell lysates (Total), cytosolic (Cyto) and nuclear (Nuc) extracts
of splenic CD4+ T cells isolated from (A) WT and 4S Tg or (B) Ceacam1−/− and
Ceacam1−/−-4S Tg (4S Tg/KO) mice with anti-NFAT1, anti-GAPDH or β-actin antibodies.
(C) Frozen sections of PP from WT or 4S Tg animals were stained with anti-CD4 (red), anti-
NFAT1 (green) and DAPI (blue). Areas of overlap are indicated by white arrows. Data are
representative of 3 pairs of animals.
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CEACAM1 regulates secretory immunity and mucosal defense against oral L.
monocytogenes infection. (A) Representative methylene blue staining of the small intestine
used to accurately quantify PP numbers. PPs are indicated by black arrows. One
representative picture from each group of three is shown. (B) Hematoxylin and eosin
staining shows 4S Tg mice have enlarged PP compared to that of WT mice. One
representative picture from each group of eight is shown. (C and D) 4S Tg mice and
Ceacam1−/−-4S Tg (4S Tg/KO) mice have significantly increased numbers and size of PP
when compared to that of WT or Ceacam1−/− mice, respectively. ***, p ≤ 0.001 (two-tailed
Student’s t test) (Mean, ± SEM.) (E–G) PP and LP in 4S Tg mice exhibit increased
B220−IgA+ plasma blasts as assessed by flow cytometry (E) while PP of Ceacam1−/− mice
possess decreased B220−IgA+ plasma blasts (F). Immunofluorescence confirmation of
enrichment of B220−IgA+ in the PP from WT or 4S Tg animals for B220 (green) and IgA
(red) (G). Data are representative of 3 animal pairs. (H–I) IgA and IgG concentrations were
measured using ELISA and compared between WT, Ceacam1−/− and 4S Tg littermates in
the small intestine (H) and serum (I). (n ≥ 12 per group) *, p < 0.05 (two-tailed Student’s t
test) (Mean, ± SD) (J) L. monocytogenes colony number (c.f.u.) in the small intestine, liver
and spleen of WT, Ceacam1−/− and 4S Tg mice 72 hour after oral infection with L.
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monocytogenes (n ≥ 9 per group). *, p < 0.05 (Mann-Whitney test). (K) IgA concentrations
for intestinal washes or serum isolated from diseased mice, as measured by ELISA. (n ≥ 9
per group). *, p < 0.05; **, p < 0.01 (Mann-Whitney t test).
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CEACAM1-4S is preferentially expressed on specific subsets of both circulating and
intestinal CD4+ T cells. (A) Expression of CEACAM1 is associated with the enrichment of
specific cell surface molecules. Percentages on histogram gates indicate the frequency of
cells positive for the given marker in the CD4+CEACAM1− and CD4+CEACAM1+ cell
populations, respectively, of MLN CD3+ T cells from WT mice. (B) CEACAM1 expression
co-segregates with LAP expression and is unrelated to Foxp3 expression in CD4+ T cells
from the MLN of naïve WT mice. (C) The CEACAM1-S isoform is enriched on CD4+CC1+
T cells which express LAP. T cells were isolated from pooled spleen and LN. (D) CXCR5 is
preferentially enriched on CEACAM1-expressing CD4+ T cells in the spleen and MLN of
WT mice. Data are representative of 5 pairs of animals. (A–C) show representative data
from 3 independent experiments with n = 5–6 mice per group.
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CEACAM1-S directly enhances the generation of CD4+LAP+ and Tfh cells. (A–D) The
percentage of CD4+LAP+ cells is increased in MLN of naïve 4S Tg mice (A) but not 4L Tg
mice (B).Ceacam1−/−-4S Tg mice (C) but not Ceacam1−/−-4L Tg mice (D) are enriched in
CD4+LAP+ T cells compared to their littermate controls. (E) Overexpression of
CEACAM1-4S enhances the regulatory function of CD4+LAP+ Treg cells in vitro as shown
by the decrease in proliferation of responder T cells when co-cultured with CD4+LAP+ Treg
cells from pooled spleen and LN of 4S Tg mice. (F) Oral feeding of anti-CD3 antibody
significantly increases the percentage of CD4+LAP+ Treg cells in the MLN of WT but not
CEACAM1−/− mice. Mice were fed 5 μg anti-CD3 (or isotype control) for each of 5
consecutive days and CD4+LAP+ T cell frequency was assessed at day 7. (G–H) The
percentage of CD4+PD1+CXCR5+ Tfh cells in the spleen, MLN and PP is increased 4S Tg
mice (G) and decreased in Ceacam1−/− mice (H) when compared to their littermate controls.
All data are representative of 3 independent experiments with n = 3–6 mice per group. All
data are mean ± SEM, *, p < 0.05; **, p < 0.01, ***, p < 0.005 (two-tailed Student’s t test).
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